These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19361529)

  • 1. An individual-based model of hepatitis A transmission.
    Ajelli M; Merler S
    J Theor Biol; 2009 Aug; 259(3):478-88. PubMed ID: 19361529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies.
    Victor JC; Surdina TY; Suleimenova SZ; Favorov MO; Bell BP; Monto AS
    Am J Epidemiol; 2006 Feb; 163(3):204-10. PubMed ID: 16339053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hepatitis A in Italy: incidence, risk factors and preventive measures.
    Tosti ME; Spada E; Romanò L; Zanetti A; Mele A;
    J Viral Hepat; 2008 Oct; 15 Suppl 2():26-32. PubMed ID: 18837830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mathematical model of hepatitis a transmission in the United States indicates value of universal childhood immunization.
    Van Effelterre TP; Zink TK; Hoet BJ; Hausdorff WP; Rosenthal P
    Clin Infect Dis; 2006 Jul; 43(2):158-64. PubMed ID: 16779741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatiotemporal dynamics of viral hepatitis A in Italy.
    Ajelli M; Fumanelli L; Manfredi P; Merler S
    Theor Popul Biol; 2011; 79(1-2):1-11. PubMed ID: 20883708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B in a high prevalence New Zealand population: a mathematical model applied to infection control policy.
    Thornley S; Bullen C; Roberts M
    J Theor Biol; 2008 Oct; 254(3):599-603. PubMed ID: 18644385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dynamic model for assessing universal Hepatitis A vaccination in Canada.
    Bauch CT; Rao AS; Pham BZ; Krahn M; Gilca V; Duval B; Chen MH; Tricco AC
    Vaccine; 2007 Feb; 25(10):1719-26. PubMed ID: 17229493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
    Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
    J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic mathematical models for the temporal dynamics of HAV in medium-endemicity Italian areas.
    Ajelli M; Iannelli M; Manfredi P; Ciofi degli Atti ML
    Vaccine; 2008 Mar; 26(13):1697-707. PubMed ID: 18314231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Viral hepatitis of enteric origin].
    Debord T; Buisson Y
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):428-31. PubMed ID: 10078380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model based analysis of hepatitis B vaccination strategies in the Netherlands.
    Kretzschmar M; Mangen MJ; van de Laar M; de Wit A
    Vaccine; 2009 Feb; 27(8):1254-60. PubMed ID: 19118594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The shifting epidemiology of hepatitis A following routine childhood immunization program in Israel.
    Chodick G; Green MS; Heymann AD; Rosenmann L; Shalev V
    Prev Med; 2007 Nov; 45(5):386-91. PubMed ID: 17599401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and case-control approaches for management of an outbreak of hepatitis A in Liguria, Italy.
    Ansaldi F; Marensi L; Puppo S; Rosselli R; Turello V; Zoppi G; Carloni R; Oreste P; Riente R; Valle L; Orsi A; Sticchi L; Durando P; Icardi G
    J Prev Med Hyg; 2007 Sep; 48(3):103-8. PubMed ID: 18274347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns.
    Jacobsen KH; Koopman JS
    Int J Epidemiol; 2005 Jun; 34(3):600-9. PubMed ID: 15831565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis A vaccination. Opinion of the Chilean Infectology Society].
    Rev Med Chil; 1996 Mar; 124(3):363-6. PubMed ID: 9008951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis A virus risk factors in a very low endemic country, Switzerland.
    Mohler-Kuo M; Steffen R; Bopp M; Jacobs RJ; Mutsch M
    Vaccine; 2007 Dec; 25(52):8718-25. PubMed ID: 18061318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Realistic population dynamics in epidemiological models: the impact of population decline on the dynamics of childhood infectious diseases. Measles in Italy as an example.
    Manfredi P; Williams JR
    Math Biosci; 2004 Dec; 192(2):153-75. PubMed ID: 15627491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroepidemiology of hepatitis A among Greek children indicates that the virus is still prevalent: Implications for universal vaccination.
    Kyrka A; Tragiannidis A; Cassimos D; Pantelaki K; Tzoufi M; Mavrokosta M; Pedeli X; Athanassiadou F; Hatzimichael A; Konstantopoulos A; Kafetzis D; Papaevangelou V
    J Med Virol; 2009 Apr; 81(4):582-7. PubMed ID: 19235841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against hepatitis A during outbreaks starting in schools: what can we learn from experiences in central Italy?
    Bonanni P; Franzin A; Staderini C; Pitta M; Garofalo G; Cecconi R; Santini MG; Lai P; Innocenti B
    Vaccine; 2005 Mar; 23(17-18):2176-80. PubMed ID: 15755590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiologic situation of viral hepatitis type A in Campania: perspectives of prevention and control of infections at the local level].
    Triassi M; Ottaiano E; Diana MV; Pennino F; Avolio S; Dattilo W; Simonetti A
    Ann Ig; 2012; 24(1):73-80. PubMed ID: 22670339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.